Researchers use High-Tech scans to see if glaucoma drops boost eye blood flow
NCT ID NCT07174401
Summary
This study aims to learn if Rocklatan eye drops improve blood flow to the retina in people with early-stage open-angle glaucoma. Researchers will use special imaging scans to measure blood flow in the eye before and after using the drops for 6 to 12 months. The goal is to understand how this common glaucoma medication works and if new devices can detect subtle changes in eye health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Casey Eye Institute - Oregon Health & Science University
Portland, Oregon, 97239, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.